Neuronetics Liabilities And Stockholders Equity Over Time
| STIM Stock | USD 0.96 0.01 1.05% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Neuronetics Performance and Neuronetics Correlation. Neuronetics |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.22) | Revenue Per Share 2.453 | Quarterly Revenue Growth (0.07) | Return On Assets (0.17) | Return On Equity (1.00) |
The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Liabilities And Stockholders Equity Analysis
Compare Neuronetics and related stocks such as Burning Rock Biotech, DarioHealth Corp, and Genetron Holdings Liabilities And Stockholders Equity Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BNR | 372.7 M | 372.7 M | 372.7 M | 372.7 M | 372.7 M | 372.7 M | 372.7 M | 372.7 M | 372.7 M | 847.6 M | 2.7 B | 2.3 B | 1.6 B | 1 B | 1.6 B |
| DRIO | 2.3 M | 2.3 M | 2.3 M | 4.1 M | 3.1 M | 5.1 M | 3.9 M | 7 M | 14.1 M | 24.6 M | 35.4 M | 100.8 M | 119.2 M | 96.4 M | 101.2 M |
| SERA | 23.3 M | 23.3 M | 23.3 M | 23.3 M | 23.3 M | 23.3 M | 23.3 M | 23.3 M | 23.3 M | 23.3 M | 14.8 M | 147 M | 116.3 M | 95.4 M | 87.3 M |
| BDSX | 39.1 M | 39.1 M | 39.1 M | 39.1 M | 39.1 M | 39.1 M | 39.1 M | 39.1 M | 39.1 M | 41.6 M | 121.1 M | 76.1 M | 92.9 M | 99.1 M | 86.1 M |
| FONR | 13.8 M | 33.6 M | 73.2 M | 76.8 M | 76.5 M | 84.9 M | 98.8 M | 118.3 M | 133.6 M | 180.3 M | 189.5 M | 199.3 M | 200.6 M | 214.2 M | 225 M |
| ENZ | 75.3 M | 69.1 M | 59 M | 64.4 M | 68.4 M | 111.8 M | 107.7 M | 101.7 M | 106.6 M | 112.5 M | 113.7 M | 95.9 M | 121.9 M | 85.8 M | 100.6 M |
| XGN | 11.3 M | 11.3 M | 11.3 M | 16.5 M | 17.1 M | 14.6 M | 20.4 M | 20.4 M | 28.9 M | 88.3 M | 78.4 M | 123.4 M | 86.2 M | 56.9 M | 54.2 M |
| SHC | 2.7 B | 2.7 B | 2.7 B | 2.7 B | 2.7 B | 2.7 B | 2.7 B | 2.7 B | 2.7 B | 2.6 B | 2.8 B | 2.8 B | 3.1 B | 3.1 B | 3.1 B |
Neuronetics and related stocks such as Burning Rock Biotech, DarioHealth Corp, and Genetron Holdings Liabilities And Stockholders Equity description
The total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation.My Equities
My Current Equities and Potential Positions
| Neuronetics | STIM |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Pennsylvania; U.S.A |
| Exchange | NASDAQ Exchange |
USD 0.96
Check out Neuronetics Performance and Neuronetics Correlation. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Neuronetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.